Warburg Pincus is a leading sponsor of biotechnology and pharmaceutical companies and globally the firm has invested more than $1 billion to build more than 40 biotechnology and pharmaceutical companies. We seek partnerships with outstanding management teams, pioneering innovative therapies to address important unmet medical needs and developing technologies capable of generating or enabling multiple products over time. We remain committed to our goal of helping the next generation of leaders build world-class biotechnology and pharmaceuticals companies.
The firm's unique, globally-integrated partnership ensures that all of our resources are committed to the success of each portfolio company. Regardless of an investment's stage of development, industry focus or geography — the right people, with the right experience, are available to every entrepreneur and management team.
